BioCentury | Dec 17, 2007
Company News

Inverness, Matritech deal

...before the deal closed (see BioCentury, Sept. 3). Inverness Medical Innovations Inc. (IMA), Waltham, Mass. Matritech Inc....
BioCentury | Oct 8, 2007
Company News

Matritech, Sysmex Corp. deal

...IMA, Waltham, Mass.) in a deal expected to close this quarter (see BioCentury, Sept. 3). Matritech Inc....
BioCentury | Sep 3, 2007
Company News

Inverness, Matritech deal

...advised IMA, and CIBC World Markets advised MZT. Inverness Medical Innovations Inc. (IMA), Waltham, Mass. Matritech Inc....
BioCentury | Jan 29, 2007
Company News

Matritech board of directors update

Matritech Inc. (MZT), Newton, Mass. Business: Cancer, Diagnostic Appointed: David Musket, president of Musket Research Associates Inc.; and Robert Rosenthal, president, CEO and a director of Magellan Biosciences Inc. WIR Staff cancer Diagnostic...
BioCentury | Jul 31, 2006
Company News

Oxford Immunotec board of directors update

...former executive director of Smith Group plc, as nonexecutive chairman; and Richard Sandberg, CFO of Matritech Inc. WIR...
BioCentury | Jun 19, 2006
Company News

Matritech board of directors update

Matritech Inc. (MZT), Newton, Mass. Business: Cancer, Diagnostic Appointed: Bruce Lahman, CEO of LehmanMillet Inc. WIR Staff...
BioCentury | Apr 3, 2006
Company News

Matritech management update

Matritech Inc. (MZT), Newton, Mass. Business: Cancer, Diagnostic Hired: David Kolasinski as VP of sales, formerly VP of business development at Inproteo LLC WIR Staff cancer Diagnostic...
BioCentury | Jan 23, 2006
Clinical News

NMP22 BladderChek Test diagnostic data

...cytoscopy alone (p=0.005). The sensitivity and specificity of NMP22 assay was 49.5% and 87.3%, respectively. Matritech Inc....
BioCentury | Dec 19, 2005
Clinical News

NMP66 diagnostic data

...immunoassay result was positive. Data were presented at the Breast Cancer meeting in San Antonio. Matritech Inc....
BioCentury | Jul 18, 2005
Clinical News

NMP22 BladderChek Test regulatory update

...in urine, to diagnose bladder cancer. BladderChek is approved in the U.S., Europe and Canada. Matritech Inc....
Items per page:
1 - 10 of 146
BioCentury | Dec 17, 2007
Company News

Inverness, Matritech deal

...before the deal closed (see BioCentury, Sept. 3). Inverness Medical Innovations Inc. (IMA), Waltham, Mass. Matritech Inc....
BioCentury | Oct 8, 2007
Company News

Matritech, Sysmex Corp. deal

...IMA, Waltham, Mass.) in a deal expected to close this quarter (see BioCentury, Sept. 3). Matritech Inc....
BioCentury | Sep 3, 2007
Company News

Inverness, Matritech deal

...advised IMA, and CIBC World Markets advised MZT. Inverness Medical Innovations Inc. (IMA), Waltham, Mass. Matritech Inc....
BioCentury | Jan 29, 2007
Company News

Matritech board of directors update

Matritech Inc. (MZT), Newton, Mass. Business: Cancer, Diagnostic Appointed: David Musket, president of Musket Research Associates Inc.; and Robert Rosenthal, president, CEO and a director of Magellan Biosciences Inc. WIR Staff cancer Diagnostic...
BioCentury | Jul 31, 2006
Company News

Oxford Immunotec board of directors update

...former executive director of Smith Group plc, as nonexecutive chairman; and Richard Sandberg, CFO of Matritech Inc. WIR...
BioCentury | Jun 19, 2006
Company News

Matritech board of directors update

Matritech Inc. (MZT), Newton, Mass. Business: Cancer, Diagnostic Appointed: Bruce Lahman, CEO of LehmanMillet Inc. WIR Staff...
BioCentury | Apr 3, 2006
Company News

Matritech management update

Matritech Inc. (MZT), Newton, Mass. Business: Cancer, Diagnostic Hired: David Kolasinski as VP of sales, formerly VP of business development at Inproteo LLC WIR Staff cancer Diagnostic...
BioCentury | Jan 23, 2006
Clinical News

NMP22 BladderChek Test diagnostic data

...cytoscopy alone (p=0.005). The sensitivity and specificity of NMP22 assay was 49.5% and 87.3%, respectively. Matritech Inc....
BioCentury | Dec 19, 2005
Clinical News

NMP66 diagnostic data

...immunoassay result was positive. Data were presented at the Breast Cancer meeting in San Antonio. Matritech Inc....
BioCentury | Jul 18, 2005
Clinical News

NMP22 BladderChek Test regulatory update

...in urine, to diagnose bladder cancer. BladderChek is approved in the U.S., Europe and Canada. Matritech Inc....
Items per page:
1 - 10 of 146